✦ LIBER ✦

PI3K signaling controls cell fate at many points in B lymphocyte development and activation

✍ Scribed by Amber C. Donahue; David A. Fruman

Book ID: 116881067
Publisher: Elsevier Science
Year: 2004
Tongue: English
Weight: 500 KB
Volume: 15
Category: Article
ISSN: 1084-9521
DOI: 10.1016/j.semcdb.2003.12.024

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PI3K signalling in B- and T-lymphocytes:

PI3K signalling in B- and T-lymphocytes: new developments and therapeutic advances

✍ So, Lomon; Fruman, David A. 📂 Article 📅 2012 🏛 Portland Press 🌐 English ⚖ 833 KB

Catalase induces the expression of induc

Catalase induces the expression of inducible nitric oxide synthase through activation of NF-κB and PI3K signaling pathway in Raw 264.7 cells

✍ Byeong-Churl Jang; Ji-Hye Paik; Sang-Pyo Kim; Jae-Hoon Bae; Kyo-Chul Mun; Dae-Ky 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 404 KB

GCN5 regulates the activation of PI3K/Ak

GCN5 regulates the activation of PI3K/Akt survival pathway in B cells exposed to oxidative stress via controlling gene expressions of Syk and Btk

✍ Hidehiko Kikuchi; Futoshi Kuribayashi; Yasunari Takami; Shinobu Imajoh-Ohmi; Tat 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 305 KB

Naringenin attenuates mucous hypersecret

Naringenin attenuates mucous hypersecretion by modulating reactive oxygen species production and inhibiting NF-κB activity via EGFR-PI3K-Akt/ERK MAPKinase signaling in human airway epithelial cells

✍ J. Yang; Q. Li; X. D. Zhou; V. P. Kolosov; J. M. Perelman 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 662 KB

Effects of pharmacologic antagonists of

Effects of pharmacologic antagonists of epidermal growth factor receptor, PI3K and MEK signal kinases on NF-κB and AP-1 activation and IL-8 and VEGF expression in human head and neck squamous cell carcinoma lines

✍ Caren C. Bancroft; Zhong Chen; Jason Yeh; John B. Sunwoo; Ning T. Yeh; Sadhana J 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 French ⚖ 296 KB 👁 2 views

## Abstract We previously reported that expression of angiogenesis factors interleukin‐8 (IL‐8) and vascular endothelial growth factor (VEGF) is promoted by coactivation of transcription factors nuclear factor‐kappaB (NF‐κB) and activator protein‐1 (AP‐1) by interleukin‐1α in human head and neck sq